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CASE SUMMARY 
Metastatic pulmonary calcifica-
tion (MPC) may develop in patients 
with secondary hyperparathyroid-
ism, related to end-stage renal disease 
(ESRD).1 The histologic pulmonary 
findings show calcium deposition in 
the lung interstitium, alveolar septa 
and bronchial walls.2 We present a 
patient with CT findings of MPC that 
resolved with medical treatment for 
secondary hyperparathyroidism. To 
our knowledge, complete resolution 
of metastatic pulmonary calcification 
following treatment has not been pre-
viously described in the literature.
IMAGING FINDINGS  
A 39-year-old male presented with 
chest radiographic findings of bilateral 
upper lobe nodular opacities compati-
ble with calcification (Figures 1). The 
patient was on hemodialysis treatment 
for the past five years for chronic renal 
failure due to biopsy proven focal scle-
rosing glomerulonephritis and long-
standing hypertension. Additional 
illnesses included hypothyroidism and 
anemia. The patient had no respiratory 
complaints. Physical examination of 
the lungs was normal. 
Chest CT scans showed scattered 
high attenuation focal nodular and 
broad linear opacities in the upper lobes 
measuring up to 210 HU (Figure 2A, 
2B). Both lower lobes were spared. The 
findings were consistent with metastatic 
pulmonary calcification. 
Laboratory results showed mild 
hypercalcemia, serum calcium lev-
els up to 12.2 (normal, <10.6 mg/dL) 
and hyperparathyroidism, parathyroid 
hormone levels up to 3189 (normal, 
<65 pg/ml). Phosphate levels were not 
performed. Treatment with Sevelamer 
carbonate and lanthanum carbonate 
was initiated for hyperparathyroidism.
During the treatment for hyperpara-
thyroidism the serum calcium, phos-
phate and parathyroid hormone levels 
varied from normal to elevated. Serum 
calcium levels varied from 5.7-11.8 
(8.4-10.6 mg/dL), serum phosphate 
levels varied from 3.2-7.3 (2.5-4.9 mg/
dL) and parathyroid hormone levels 
varied from 35.5-3116 (10-65 pg/ml). 
A follow-up chest CT scan per-
formed 18 months later revealed near 
complete resolution of the calcified 
focal air space consolidation in both 
upper lobes. A minimal scar remained 
in the left upper lobe while all other 
lesions resolved without scarring (Fig-
ure 3A, 3B).
Because the secondary hyperpara-
thyroidism remained out of control, a 
subtotal parathyroidectomy was per-
formed approximately one year after 
complete resolution of the metastatic 
pulmonary calcification. Post-opera-
tive parathyroid hormone levels gradu-
ally decreased to normal, 14 pg/ml.
DIAGNOSIS
Metastatic pulmonary calcification
DISCUSSION  
We present a patient with meta-
static pulmonary calcification. A most 
unusual finding was the complete reso-
lution of pulmonary calcification after 
18 months of medical treatment for 
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FIGURE 1. Routine PA chest radiograph shows nodular opacities in both upper lobes (sin-
gle arrows). The focal right upper lobe calcification represents a longstanding calcified gran-
uloma (double arrows). 
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secondary hyperparathyroidism. To 
our knowledge, complete resolution of 
metastatic pulmonary calcification has 
never been described in the literature. 
Partial resolution had been reported in 
one patient in a case series by Edson 
Marchiori, et al.3 
Laboratory results showed serum 
calcium, phosphorus and parathyroid 
levels were elevated prior to medical 
treatment. After initiation of medi-
cal treatment serum levels fluctuated 
from normal to elevated, but the lev-
els were trending toward normal. The 
trending to normal values with medical 
treatment may have been sufficient to 
promote dissolution of the pulmonary 
calcifications. Parathyroidectomy was 
performed for better control of the sec-
ondary hyperparathyroidism but the 
surgery was performed after the met-
astatic pulmonary calcifications had 
resolved.
Metastatic pulmonary calcification 
is a well-recognized complication of 
ESRD secondary to abnormal calcium 
metabolism.2,4 The process is poorly 
understood.5 Pathologically, there is 
deposition of calcium salt in lung inter-
stitium, the alveolar and vessel wall of 
normal lung.6 Deposition of calcium 
and phosphate can occur in any tissue, 
most commonly in the lungs, but also 
in kidney and stomach.7  
The actual cause of metastatic pul-
monary calcification is presumably 
related to the balance of serum cal-
cium, phosphate and vitamin D.1,8 
Reported risk factors include hyper-
calcemia, hyperphosphatemia, and 
elevated plasma calcium-phosphate 
product. The most common presen-
tation is in patients on hemodialysis 
for chronic renal failure with second-
ary hyperparathyroidism (Kuhlman 
FIGURE 2. (A) Chest CT scan with lung windows shows the left upper lobe opacity. The opacity shows an irregular shape with a small cluster 
of nodules anteriorly (single arrows) and a broad linear opacity posteriorly (double arrows). (B) Chest CT scan with lung windows shows mul-
tifocal indistinct nodules of varying size in the right upper lobe.
FIGURE 3. (A) An 18-month follow-up axial chest CT scan displayed in lung window at the corresponding level of left upper lobe opacity. 
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JE-Radiology (1990)) as seen in our 
case. The incidence of metastatic pul-
monary calcification is found up to 
60 percent to 75 percent in autopsy of 
hemodialysis patients.8 
Metastatic pulmonary calcifica-
tion may also develop in patients with 
primary hyperparathyroidism; malig-
nancy, including multiple myeloma 
and parathyroid carcinoma; protein 
C deficiency; hypervitaminosis D, 
milk-alkali syndrome or receiving 
warfarin therapy.1,5,7,9,10,11 Patients are 
usually asymptomatic but fatal respira-
tory failure can occur in some cases.3 
Most of the patients are asymptom-
atic; however, fatal pulmonary com-
plications can occur such as restricted 
lung function due to fibrosis, hypoxia 
and respiratory failure.12 Diagnosis 
sometime can be difficult since the 
autopsy is rarely performed.13
Imaging in patients susceptible to 
this condition may inadvertently sug-
gest the diagnosis. Chest radiographs 
can demonstrate the development of 
pulmonary opacities but are not effec-
tive for calcium detection.3 However, 
the chest radiograph may provide a 
clue for further investigation with 
chest CT. 
Chest CT and Tc-99m bone imaging 
have been reported to be most useful 
for diagnosis.15 Chest CT can be used to 
characterize the pattern and location of 
calcium deposition. The upper lobe pre-
dominance as demonstrated in our case 
can be explained by the alkaline environ-
ment in the upper lobes that promotes the 
precipitation of calcium salts.3 Upper-
lobe alkalinity can be explained by an 
increased upper lobe ventilation-perfu-
sion ratio (3:1) compared to the lower 
lung V/Q ratio (0.6:1). 
The most common CT parenchymal 
finding is centrilobular ground glass 
nodular opacities ranging from 3-10 
mm in diameter. Other patterns include 
multiple diffuse calcified nodules, dif-
fuse or patchy ground glass opacities, or 
high attenuation parenchymal consoli-
dation in a lobar distribution.15,16,17 Cal-
cification, if present, can have various 
features, including punctuate, ring-like 
pattern or diffuse calcification.3,15,18 
A well-recognized finding in 99m 
Tc methylene diphosphonate (MDP) 
bone scintigraphy is intense accumu-
lation of the radioactive tracer in both 
lungs, stomach and kidneys.19 
MRI is not the modality of choice 
for this entity, but it may inadvertently 
show pulmonary calcification. The 
signal intensity of the calcification is 
unusual, demonstrating low signal inten-
sity on T1WI and isosignal intensity on 
T2WI compared to the skeletal muscles, 
according to B. Hochhegger, et al.4  
The differential diagnosis for pul-
monary calcification includes dys-
trophic calcification in a prior injured 
lung as seen with infection mostly 
from tuberculosis or histoplasmosis, 
pulmonary hematoma or infarction, 
amyloidosis, necrotic tumors and other 
etiologies.7 
A limitation of our report is the 
lack of pathological proof to support 
our diagnosis. Our radiologic diagno-
sis was based on the patient’s clinical 
presentation and diagnostic imaging 
features. 
CONCLUSION  
Metastatic pulmonary calcifica-
tion in ESRD patients with second-
ary hyperparathyroidism can resolve 
completely with medical treatment as 
demonstrated n our patient.  
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